Decembrino Nunzia, Leonardi Roberta, Fedeli Tiziana, Conte Luana, Distefano Chiara, Pozzi Nicola, Fichera Valeria, Spagnuolo Ferdinando, Gizzi Camilla, Mosca Fabio, Orfeo Luigi, Gitto Eloisa
Neonatal Intensive Care Unit, University Hospital Policlinico "G. Rodolico San Marco", University of Catania, Catania, Italy.
Postgraduate Training Programme in Pediatrics, Department of Clinical and Esperimental Medicine, University of Catania, Catania, Italy.
Ital J Pediatr. 2025 Jun 17;51(1):192. doi: 10.1186/s13052-025-01977-x.
The shortage of Pediatric Intensive Care Unit (PICU) beds among some Italian regions is a major concern, especially during epidemics. During respiratory syncytial virus (RSV) bronchiolitis peak, Neonatal Intensive Care Units (NICU) often admit infants and toddlers requiring advanced respiratory support. We conducted a survey to quantify children hospitalized for RSV bronchiolitis in NICU in 2021 and to examine the adherence to treatment guidelines.
Early Childhood Intensive Care Working Group of the Italian Society of Neonatology (SIN) conducted a survey distributed to SIN Network NICUs. The modified Delphi method was used to prepare the survey; duplicate responses were excluded. Analysis evaluated percentages.
Response rate was 67% (78/117 NICUs). Geographic distribution of responding centers was: 51% Southern-Islands, 38% North, 11% Center; 50% were Territorial Hospitals, 20% University Hospitals. Of respondents, 55% have 5-10 NICU beds; 70% routinely admit children > 44 weeks postconceptional age and > 28 days old, with a rate of < 10 toddlers/year in 50% of cases, 10-20 toddlers/year in 25% of cases and > 20 toddlers/year in 15%. In 2021, 40% of NICUs admitted < 10 bronchiolitis cases, 29% 11-20 cases. RSV was the leading cause of bronchiolitis. Reasons for NICU admission were respiratory distress syndrome (92%), feeding difficulties (58%), comorbidities (20%). High-flow oxygen (87%) and non-invasive ventilation (60%) were common respiratory supports provided; 10% of patients needed invasive ventilation. Treatment included inhaled steroids (46%), bronchodilators/systemic steroids (32%), antibiotics (40%); 60% of centers did not use sedation during NIV; 30% used midazolam, 13% dexmedetomidine, < 10% fentanyl.
Our survey highlights that during the RSV epidemic, NICUs admitted toddlers to receive advanced respiratory support unavailable in pediatric ICUs. Most of the NICUs admitted fewer than 10 toddlers per year and less than 10 bronchiolitis, posing skill challenges for medical staff. This supports SIN's proposal to identify some "extended NICUs" in regions with limited PICU beds, to centralize toddlers after an adequate training to gain knowledge/technical skills specific of pediatric critical care. This would help to overcome the PICU beds storage. Adherence to bronchiolitis management guidelines resulted suboptimal, with frequent but unrecommended use of inhaled steroids, bronchodilators, and antibiotics.
意大利一些地区儿科重症监护病房(PICU)床位短缺是一个主要问题,尤其是在疫情期间。在呼吸道合胞病毒(RSV)毛细支气管炎高峰期,新生儿重症监护病房(NICU)经常收治需要高级呼吸支持的婴幼儿。我们进行了一项调查,以量化2021年在NICU因RSV毛细支气管炎住院的儿童数量,并检查对治疗指南的遵循情况。
意大利新生儿学会(SIN)的幼儿重症监护工作组对SIN网络中的NICU进行了一项调查。采用改良德尔菲法编制调查问卷;重复回复被排除。分析评估百分比。
回复率为67%(78/117个NICU)。回复中心的地理分布为:51%在南部岛屿,38%在北部,11%在中部;50%是地区医院,20%是大学医院。在受访者中,55%的NICU有5 - 10张床位;70%的科室常规收治孕龄>44周且年龄>28天的儿童,50%的科室每年收治的幼儿<10名,25%的科室每年收治10 - 20名幼儿,15%的科室每年收治>20名幼儿。2021年,40%的NICU收治的毛细支气管炎病例<10例,29%的科室收治11 - 20例。RSV是毛细支气管炎的主要病因。NICU收治的原因有呼吸窘迫综合征(92%)、喂养困难(58%)、合并症(20%)。常用的呼吸支持措施有高流量吸氧(87%)和无创通气(60%);10%的患者需要有创通气。治疗包括吸入性糖皮质激素(46%)、支气管扩张剂/全身性糖皮质激素(32%)、抗生素(40%);60%的中心在无创通气期间不使用镇静剂;30%使用咪达唑仑,13%使用右美托咪定,<10%使用芬太尼。
我们的调查强调,在RSV疫情期间,NICU收治幼儿以提供儿科重症监护病房无法提供的高级呼吸支持。大多数NICU每年收治的幼儿少于10名,毛细支气管炎病例少于10例,这给医护人员带来了技能挑战。这支持了SIN的提议,即在PICU床位有限的地区确定一些“扩展NICU”,在进行充分培训以获得儿科重症监护特定的知识/技术技能后,集中收治幼儿。这将有助于克服PICU床位短缺的问题。对毛细支气管炎管理指南的遵循情况不理想,吸入性糖皮质激素、支气管扩张剂和抗生素的使用频繁但不推荐。